<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16778">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02089009</url>
  </required_header>
  <id_info>
    <org_study_id>NonMydGyn</org_study_id>
    <nct_id>NCT02089009</nct_id>
  </id_info>
  <brief_title>Comparison of Non-mydriatic Camera Systems in a Female Health Hospital</brief_title>
  <official_title>Comparison of Non-mydriatic Camera Systems for Screening and Follow-up Examinations -Focused on the Retinal Vessel Situation- in the Population of a Female Health Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Martin Leitritz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Optomed</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To compare quality and usability of images taken by two different camera-systems
           without dilating the pupil.

        2. To compare the retinal vessel diameters based on the images of to different
           camera-systems.

        3. To detect changes in retinal vessel diameters while pregnancy and after delivery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Image Quality</measure>
    <time_frame>12 to 16 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visit 1 and Visit 2 (for group 2) Evaluating of image quality for each camera-system</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Image Usability</measure>
    <time_frame>12 to 16 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visit 1 and Visit 2 (for Group 2) Evaluation of the usability of taken images to perform automated measurements of retinal vessel diameters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Differences Perinatal</measure>
    <time_frame>12 to 16 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visit 1 and Visit 2 (group 2) Grading of perinatal differences in vessel diameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retinal Pathologies</measure>
    <time_frame>12 to 16 month</time_frame>
    <safety_issue>No</safety_issue>
    <description>Visit 1 and Visit 2 (group 2) Which pathologies  / diseases can be assessed with the taken images.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">345</enrollment>
  <condition>Retinal Imaging</condition>
  <condition>Vessel Grading</condition>
  <arm_group>
    <arm_group_label>Group 1 Retinal Imaging, Vessel measurements</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Retinal Imaging of a population of a female health hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2 Retinal Imaging Vessel measurements, Vessel changes</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Comparison of vessel diameters of two perinatal visits with retinal imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retinal imaging</intervention_name>
    <arm_group_label>Group 1 Retinal Imaging, Vessel measurements</arm_group_label>
    <arm_group_label>Group 2 Retinal Imaging Vessel measurements, Vessel changes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Vessel measurements</intervention_name>
    <arm_group_label>Group 1 Retinal Imaging, Vessel measurements</arm_group_label>
    <arm_group_label>Group 2 Retinal Imaging Vessel measurements, Vessel changes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Change of vessel diameters</intervention_name>
    <arm_group_label>Group 2 Retinal Imaging Vessel measurements, Vessel changes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  age &gt;18 years

          -  pregnancy (only group 2)

        Exclusion Criteria:

          -  limited ability for agreement

          -  heavy treamble

          -  reduced general condition

          -  known epilepsy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin A Leitritz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Eye-Hospital Tuebingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin A Leitritz, M.D.</last_name>
    <phone>0049-7071-2983721</phone>
    <email>martin.leitritz@med.uni-tuebingen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Female Health Hospital Reutlingen</name>
      <address>
        <city>Reutlingen</city>
        <state>BW</state>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Norrenberg, M.D.</last_name>
      <email>norrenberg_l@klin-rt.de</email>
    </contact>
    <investigator>
      <last_name>Lars Norrnberg, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Tuebingen</city>
        <state>BW</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Martin A Leitritz, M.D.</last_name>
      <email>martin.leitritz@med.uni-tuebingen.de</email>
    </contact>
    <investigator>
      <last_name>Martin A Leitritz, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 13, 2014</lastchanged_date>
  <firstreceived_date>March 11, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Tuebingen</investigator_affiliation>
    <investigator_full_name>Dr. Martin Leitritz</investigator_full_name>
    <investigator_title>Dr. med. Martin A. Leitritz</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
